Indies Pharma Jamaica Income Statement

Financials in millions JMD. Fiscal year is November - October.

Millions JMD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	1,081	1,126	1,159	1,055	937.28	846.83
Revenue Growth (YoY)	-11.06%	-2.82%	9.81%	12.61%	10.68%	10.56%
Cost of Revenue	449.98	457.76	465.82	417.41	323.44	329.81
Gross Profit	630.73	668.56	693.15	638.05	613.84	517.02
Selling, General & Admin	357.01	347.67	354.55	308.57	273.53	244.65
Other Operating Expenses	-10.29	-8.04	-6.41	-4.23	1.15	1.5
Operating Expenses	412.39	405.3	410.01	367.82	332.13	299.61
Operating Income	218.34	263.27	283.15	270.24	281.71	217.41
Interest Expense	-75.63	-62.71	-64.46	-66.78	-60.48	-68.96
Interest & Investment Income	1.74	1.74	1.6	1.46	0.95	4.84
Currency Exchange Gain (Loss)	0.17	0.72	8.78	1.86	-1.75	14.76
Other Non Operating Income (Expenses)	-3.04	-2.66	-2.95	-3.29	-2.22	-2.59
EBT Excluding Unusual Items	141.59	200.37	226.12	203.48	218.21	165.47
Gain (Loss) on Sale of Assets	-	-	1.55	3.07	1.88	2.4
Pretax Income	141.59	200.37	251.77	217.63	220.79	167.87
Income Tax Expense	12.73	19.08	30.6	4.58	-	-
Net Income	128.86	181.29	221.18	213.06	220.79	167.87
Net Income to Common	128.86	181.29	221.18	213.06	220.79	167.87
Net Income Growth	-44.67%	-18.04%	3.81%	-3.50%	31.53%	-19.04%
Shares Outstanding (Basic)	1,341	1,333	1,333	1,333	1,333	1,333
Shares Outstanding (Diluted)	1,341	1,333	1,333	1,333	1,333	1,333
Shares Change (YoY)	0.75%	-	-	-	-	-
EPS (Basic)	0.10	0.14	0.17	0.16	0.17	0.13
EPS (Diluted)	0.10	0.14	0.17	0.16	0.17	0.13
EPS Growth	-45.08%	-18.04%	3.81%	-3.50%	31.53%	-19.04%
Free Cash Flow	287.76	320.3	241.13	265.45	288.85	325.76
Free Cash Flow Per Share	0.21	0.24	0.18	0.20	0.22	0.24
Dividend Per Share	0.135	0.135	0.110	0.110	0.113	0.110
Dividend Growth	22.73%	22.73%	-	-2.66%	2.73%	-21.43%
Gross Margin	58.36%	59.36%	59.81%	60.45%	65.49%	61.05%
Operating Margin	20.20%	23.37%	24.43%	25.60%	30.06%	25.67%
Profit Margin	11.92%	16.10%	19.08%	20.19%	23.56%	19.82%
Free Cash Flow Margin	26.63%	28.44%	20.80%	25.15%	30.82%	38.47%
EBITDA	246.87	288.01	303.32	289.13	300.95	233.54
EBITDA Margin	22.84%	25.57%	26.17%	27.39%	32.11%	27.58%
D&A For EBITDA	28.52	24.74	20.17	18.9	19.24	16.13
EBIT	218.34	263.27	283.15	270.24	281.71	217.41
EBIT Margin	20.20%	23.37%	24.43%	25.60%	30.06%	25.67%
Effective Tax Rate	8.99%	9.52%	12.15%	2.10%	-	-
Advertising Expenses	-	11.52	10.72	5.27	4.98	6.5

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.